Royal Bank Of Canada reissued their hold rating on shares of Chemed Corp. (NYSE:CHE) in a report issued on Friday morning. Royal Bank Of Canada currently has a $209.00 price target on the stock.

Several other analysts have also commented on CHE. BidaskClub lowered shares of Chemed Corp. from a strong-buy rating to a buy rating in a research note on Thursday, June 22nd. TheStreet lowered shares of Chemed Corp. from a b+ rating to a c+ rating in a research note on Tuesday, July 25th. Oppenheimer Holdings, Inc. increased their target price on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an outperform rating in a research note on Thursday, July 27th. Zacks Investment Research raised shares of Chemed Corp. from a hold rating to a buy rating and set a $226.00 target price for the company in a research note on Friday, July 28th. Finally, KeyCorp started coverage on shares of Chemed Corp. in a research note on Monday, August 28th. They set a sector weight rating for the company. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $214.00.

Chemed Corp. (NYSE CHE) traded up 0.05% during midday trading on Friday, hitting $197.38. 95,726 shares of the stock were exchanged. The firm’s 50-day moving average is $196.29 and its 200 day moving average is $194.53. The stock has a market cap of $3.16 billion, a price-to-earnings ratio of 48.97 and a beta of 1.14. Chemed Corp. has a 52 week low of $132.92 and a 52 week high of $216.01.

Chemed Corp. (NYSE:CHE) last released its earnings results on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The business had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. During the same period in the prior year, the business earned $1.80 earnings per share. The business’s quarterly revenue was up 6.3% on a year-over-year basis. Equities research analysts expect that Chemed Corp. will post $8.21 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/02/chemed-corp-che-receives-hold-rating-from-royal-bank-of-canada.html.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 1st. Investors of record on Monday, August 14th were paid a dividend of $0.28 per share. The ex-dividend date was Thursday, August 10th. This is a positive change from Chemed Corp.’s previous quarterly dividend of $0.26. This represents a $1.12 annualized dividend and a yield of 0.57%. Chemed Corp.’s dividend payout ratio is currently 28.07%.

In related news, insider Spencer S. Lee sold 1,000 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the completion of the sale, the insider now directly owns 37,809 shares of the company’s stock, valued at $7,465,765.14. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Kevin J. Mcnamara sold 15,000 shares of the stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $201.16, for a total transaction of $3,017,400.00. Following the sale, the insider now directly owns 173,801 shares of the company’s stock, valued at $34,961,809.16. The disclosure for this sale can be found here. 5.32% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of CHE. BlackRock Inc. increased its stake in shares of Chemed Corp. by 145,760.9% in the first quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock valued at $357,341,000 after buying an additional 1,954,653 shares during the period. Vanguard Group Inc. increased its stake in shares of Chemed Corp. by 7.5% in the first quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock valued at $328,070,000 after buying an additional 125,018 shares during the period. Voya Investment Management LLC increased its stake in shares of Chemed Corp. by 39.7% in the second quarter. Voya Investment Management LLC now owns 214,764 shares of the company’s stock valued at $43,926,000 after buying an additional 61,056 shares during the period. Renaissance Technologies LLC increased its stake in shares of Chemed Corp. by 248.5% in the second quarter. Renaissance Technologies LLC now owns 70,400 shares of the company’s stock valued at $14,399,000 after buying an additional 50,200 shares during the period. Finally, State Street Corp increased its stake in shares of Chemed Corp. by 9.1% in the first quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after buying an additional 37,085 shares during the period. Institutional investors and hedge funds own 96.96% of the company’s stock.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.